The conjunction of emerging infectious diseases, the rapid rise of resistance to antibiotic and antiviral drugs, and the sluggish pipeline for new anti-infectives puts us at the eye of a perfect storm. This talk will explore the environmental and societal challenges that are responsible for the global surge of novel pathogens as well as old pathogens in new places. How is the healthcare industry dealing with this new reality? How, as a global community, are we to deal with (when not if) pandemics, quarantine laws, and the critical development of radically new anti-infectives.
Presented by:
Professor and Director of the Beckman Center for Molecular and Genetic Medicine, Stanford University School of Medicine
No slides availableSave the date!
Please join on May 16-17, 2024